Novavax stock plunges after quarterly earnings, but company sees hope in licensing deals

FDA clears Novavax to resume trials of Covid-19 and flu combo vaccine

Moderna’s mRESVIA vaccine gains Health Canada approval

Earnings Beat: Moderna, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Moderna's Q3 Earnings Beat Overshadowed By Vaccine Demand Slowdown And Market Share Concerns, Analysts Warn

2 Biotech Stocks You Can Buy Hand Over Fist This Month

Moderna (MRNA) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

Is Moderna Stock A Sell After A Key Nuance Undercut Its Third-Quarter Beat?

Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma

Moderna Receives Health Canada Approval for RSV Vaccine for Adults Aged 60 Years and Older

Moderna Third Quarter 2024 Earnings: Beats Expectations

Moderna Inc (MRNA) Q3 2024 Earnings Call Highlights: Strong Revenue and Strategic Growth Amidst ...